Table 5.
Electrophysiology service’s additional recommendations made after discussion with the primary team
| Additional recommendations made | Value |
|---|---|
| Magnesium repletion | 25 (24.3) |
| Discontinuing nonessential/use non–QT-prolonging alternative | 18 (17.5) |
| Potassium repletion | 4 (3.9) |
| Continue COVID-19 treatment | 8 (7.8) |
| Telemetry/ECG monitoring | 5 (4.9) |
| Discontinuing antiarrhythmics | 4 (3.9) |
| Continuing antiarrhythmics | 3 (2.9) |
| Dose adjustment | 2 (1.9) |
Values are presented as n (%).
COVID-19 = coronavirus disease 2019; ECG = electrocardiographic.